These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20044785)

  • 1. Treatment of inclusion body myositis: is low-dose intravenous immunoglobulin the solution?
    Recher M; Sahrbacher U; Bremer J; Arndt B; Steiner U; Fontana A
    Rheumatol Int; 2012 Feb; 32(2):469-72. PubMed ID: 20044785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
    Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE
    Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current therapy for polymyositis and dermatomyositis].
    Chérin P
    Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose immunoglobulin therapy in sporadic inclusion body myositis: a double-blind, placebo-controlled study.
    Walter MC; Lochmüller H; Toepfer M; Schlotter B; Reilich P; Schröder M; Müller-Felber W; Pongratz D
    J Neurol; 2000 Jan; 247(1):22-8. PubMed ID: 10701893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of intravenous immunoglobulin therapy for myositis: an audit in South Australian patients.
    Foreman C; Russo P; Davies N; Hissaria P; Proudman S; Hughes T; Limaye V
    Intern Med J; 2017 Jan; 47(1):112-115. PubMed ID: 28076913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis.
    Dalakas MC
    Neurology; 1998 Dec; 51(6 Suppl 5):S37-45. PubMed ID: 9851729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A rare case of inclusion body myositis associated with anti-PM/Scl-75 antibodies].
    Yamamoto M; Tsuzaki K; Itani K; Tachibana N; Inoue M; Hamano T
    Rinsho Shinkeigaku; 2020 Apr; 60(4):264-267. PubMed ID: 32238743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of inclusion body myositis with cyclosporin-A or tacrolimus: successful long-term management in patients with earlier active disease and concomitant autoimmune features.
    Quartuccio L; De Marchi G; Scott CA; Ferraccioli G; Beltrami CA; De Vita S
    Clin Exp Rheumatol; 2007; 25(2):246-51. PubMed ID: 17543149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study.
    Dalakas MC; Sonies B; Dambrosia J; Sekul E; Cupler E; Sivakumar K
    Neurology; 1997 Mar; 48(3):712-6. PubMed ID: 9065553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of action of intravenous immunoglobulin in inflammatory muscle disease.
    Quick A; Tandan R
    Curr Rheumatol Rep; 2011 Jun; 13(3):192-8. PubMed ID: 21503696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term observational study of sporadic inclusion body myositis.
    Benveniste O; Guiguet M; Freebody J; Dubourg O; Squier W; Maisonobe T; Stojkovic T; Leite MI; Allenbach Y; Herson S; Brady S; Eymard B; Hilton-Jones D
    Brain; 2011 Nov; 134(Pt 11):3176-84. PubMed ID: 21994327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin in patients with anti-GAD antibody-associated neurological diseases and patients with inflammatory myopathies: effects on clinicopathological features and immunoregulatory genes.
    Dalakas MC
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):255-69. PubMed ID: 16391401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of sporadic inclusion body myositis treated with intravenous immunoglobulin: a retrospective study of 16 patients.
    Dobloug C; Walle-Hansen R; Gran JT; Molberg Ø
    Clin Exp Rheumatol; 2012; 30(6):838-42. PubMed ID: 22935197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion body myositis: therapeutic approaches. A case report.
    Kierdaszuk B; Kamińska A
    Neurol Neurochir Pol; 2011; 45(1):68-73. PubMed ID: 21384296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous immunoglobulin treatment of inclusion-body myositis stabilizes dysphagia.
    Pars K; Garde N; Skripuletz T; Pul R; Dengler R; Stangel M
    Muscle Nerve; 2013 Nov; 48(5):838-9. PubMed ID: 23649689
    [No Abstract]   [Full Text] [Related]  

  • 16. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM.
    Dalakas MC; Koffman B; Fujii M; Spector S; Sivakumar K; Cupler E
    Neurology; 2001 Feb; 56(3):323-7. PubMed ID: 11171896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent anti-PM-Scl antibody-associated systemic sclerosis and inclusion body myositis - report of two cases and review of the literature.
    Chatterjee S; Prayson RA
    Semin Arthritis Rheum; 2020 Jun; 50(3):498-502. PubMed ID: 31806155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: quantitative assessment of inflammation and β-amyloid in the muscle.
    Zschüntzsch J; Voss J; Creus K; Sehmisch S; Raju R; Dalakas MC; Schmidt J
    Arthritis Rheum; 2012 Dec; 64(12):4094-103. PubMed ID: 22941914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.